Opportunity ID: 349560

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-AG-24-044
Funding Opportunity Title: Pharmacokinetic and Pharmacodynamic (PK/PD) Studies of mTOR Inhibitors on Aging-Related Indications (U01 Clinical Trial Required)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.866 — Aging Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Jul 26, 2023
Last Updated Date: Jul 26, 2023
Original Closing Date for Applications: Nov 07, 2023
Current Closing Date for Applications: Nov 07, 2023
Archive Date: Dec 13, 2023
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
For profit organizations other than small businesses
Small businesses
Private institutions of higher education
State governments
Independent school districts
Public housing authorities/Indian housing authorities
City or township governments
County governments
Special district governments
Public and State controlled institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Native American tribal governments (Federally recognized)
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.

Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.

Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name: National Institutes of Health
Description: This Notice of Funding Opportunity (NOFO) invites applications for pharmacokinetic and pharmacodynamic (PK/PD) studies of mTOR inhibitors inpopulations living with different aging-related diseases or in relatively healthy older adult populations at risk for a variety of aging conditions. The studies will be funded by individual awards but will be required to interact as a network to exchange information, possibly develop harmonized measures, and pool data to facilitate broader assessment of the effects on multiple aging-related outcomes and mechanisms affected by mTOR modulation.
Link to Additional Information: https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-24-044.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH Grants Information
grantsinfo@nih.gov
Email:grantsinfo@nih.gov

Version History

Version Modification Description Updated Date

Folder 349560 Full Announcement-RFA-AG-24-044 -> RFA-AG-24-044-Full-Announcement.pdf

Packages

Agency Contact Information: NIH Grants Information
grantsinfo@nih.gov
Email: grantsinfo@nih.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-H Use for due dates on or after January 25, 2023 PKG00282673 Oct 06, 2023 Nov 07, 2023 View

Package 1

Mandatory forms

349560 RR_SF424_5_0-5.0.pdf

349560 PHS398_CoverPageSupplement_5_0-5.0.pdf

349560 RR_OtherProjectInfo_1_4-1.4.pdf

349560 PerformanceSite_4_0-4.0.pdf

349560 RR_KeyPersonExpanded_4_0-4.0.pdf

349560 PHS398_ResearchPlan_5_0-5.0.pdf

349560 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

349560 RR_Budget_3_0-3.0.pdf

349560 RR_SubawardBudget30_3_0-3.0.pdf

349560 PHS398_ModularBudget_1_2-1.2.pdf

349560 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-11T07:36:13-05:00

Share This Post, Choose Your Platform!

About the Author: